← Leaderboards
Pankaj Kapahi
Buck Institute For Age Research
$21,454,019
Attributed
$22,777,959
Total exposure
19
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,777,959 · 19
By mechanism
R01$14,214,388 · 7
RL1$3,169,316 · 1
R21$2,850,047 · 5
R56$2,393,123 · 4
R13$151,085 · 2
Top collaborators
- Rachel Beth Brem3 shared
- Marshall Stoller2 shared
- Cristina Aguayo-Mazzucato1 shared
- Lisa M. Ellerby1 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAgingMediatingPathway InteractionsAge RelatedBaseGenesGeneticLongevityMetabolismProteinsMolecularNerve DegenerationPlayLinkDietMetabolicTissuesNutrientDietary RestrictionDiabetes MellitusResponseMalignant NeoplasmsSignal Pathway
Grant awards (55)
The role of diet and aging in photoreceptor homeostasis and visual function decline$730,509
R01 · FY2025 · AG · contact PI
Summer Training Course in Experimental Aging$101,085
R13 · FY2025 · AG · contact PI
The role of diet and aging in photoreceptor homeostasis and visual function decline$745,418
R01 · FY2024 · AG · contact PI
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease$485,000
R01 · FY2024 · AG · contact PI
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.$646,911
R01 · FY2023 · AG · contact PI
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease$485,000
R01 · FY2023 · AG · contact PI
Investigating the interplay between hallmarks of aging; protein glycation, nutrient sensing, and senescence$444,220
R56 · FY2023 · AG · contact PI
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease$115,399
R01 · FY2023 · AG · contact PI
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.$646,911
R01 · FY2022 · AG · contact PI
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease$485,000
R01 · FY2022 · AG · contact PI
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease$80,110
R01 · FY2022 · AG · contact PI
Determining the role of OXR1 in aging and Alzheimer's disease$851,414
R56 · FY2021 · AG · contact PI
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.$646,911
R01 · FY2021 · AG · contact PI
Targeting conserved diet-responsive transcriptional networks in neurons to slow neurodegeneration in Alzheimer's disease$533,500
R21 · FY2021 · AG · contact PI
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease$485,000
R01 · FY2021 · AG · contact PI
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.$646,911
R01 · FY2020 · AG · contact PI
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease$485,000
R01 · FY2020 · AG · contact PI
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.$670,411
R01 · FY2019 · AG · contact PI
Advanced glycation end products as non-autonomous factors that drive aging$485,000
R56 · FY2018 · AG · contact PI
The role of natural genetic variants in nutrient-dependent changes in healthspan using D. melanogaster$291,000
R21 · FY2018 · AG · contact PI
The role of natural genetic variants in nutrient-dependent changes in healthspan using D. melanogaster$291,000
R21 · FY2018 · AG · contact PI
Molecular Mechanisms of Lifespan Extension by Dietary Restriction in Drosophila$612,489
R56 · FY2017 · AG · contact PI
Role of Circadian Clocks in Aging using Drosophila$339,500
R01 · FY2017 · AG · contact PI
The role of advanced glycation end products in modulating healthspan using C. elegans$291,000
R21 · FY2017 · AG · contact PI
The role of natural genetic variants in nutrient-dependent changes in healthspan using D. melanogaster$242,500
R21 · FY2017 · AG · contact PI
Role of Circadian Clocks in Aging using Drosophila$194,000
R01 · FY2017 · AG · contact PI
Role of Circadian Clocks in Aging using Drosophila$93,370
R01 · FY2017 · AG · contact PI
Role of Circadian Clocks in Aging using Drosophila$339,500
R01 · FY2016 · AG · contact PI
The role of advanced glycation end products in modulating healthspan using C. elegans$242,500
R21 · FY2016 · AG · contact PI
Molecular Mechanisms of Lifespan Extension by Dietary Restriction in Drosophila$450,617
R01 · FY2015 · AG · contact PI
Role of Circadian Clocks in Aging using Drosophila$329,315
R01 · FY2015 · AG · contact PI
Role of Circadian Clocks in Aging using Drosophila$97,000
R01 · FY2015 · AG · contact PI
Molecular Mechanisms of Lifespan Extension by Dietary Restriction in Drosophila$466,440
R01 · FY2014 · AG · contact PI
Role of Circadian Clocks in Aging using Drosophila$339,500
R01 · FY2014 · AG · contact PI
Molecular Mechanisms of Lifespan Extension by Dietary Restriction in Drosophila$442,598
R01 · FY2013 · AG · contact PI
Role of mRNA translation in the effects of dietary restriction on lifespan$352,434
R01 · FY2013 · AG · contact PI
Role of Circadian Clocks in Aging using Drosophila$339,500
R01 · FY2013 · AG · contact PI
A model of kidney stone disease using D. melanogaster$271,703
R21 · FY2013 · DK · contact PI
2013 Aging, Biology of Gordon Research Conference and Gordon Research Seminar$50,000
R13 · FY2013 · AG · contact PI
Molecular Mechanisms of Lifespan Extension by Dietary Restriction in Drosophila$475,322
R01 · FY2012 · AG · contact PI
Role of mRNA translation in the effects of dietary restriction on lifespan$372,946
R01 · FY2012 · AG · contact PI
A model of kidney stone disease using D. melanogaster$256,044
R21 · FY2012 · DK · contact PI
Molecular Mechanisms of Lifespan Extension by Dietary Restriction in Drosophila$496,909
R01 · FY2011 · AG · contact PI
mRNA Translation, TOR and Geroscience (2 of 11)$466,318
RL1 · FY2011 · AG · contact PI
Role of mRNA translation in the effects of dietary restriction on lifespan$372,946
R01 · FY2011 · AG · contact PI
TOR, mRNA Translation and Dietary Restriction in Drosophila$485,000
R01 · FY2010 · AG · contact PI
mRNA Translation, TOR and Geroscience (2 of 11)$471,028
RL1 · FY2010 · AG · contact PI
Role of mRNA translation in the effects of dietary restriction on lifespan$388,000
R01 · FY2010 · AG · contact PI
mRNA Translation, TOR and Geroscience (2 of 11)$795,400
RL1 · FY2009 · AG · contact PI
TOR, mRNA Translation and Dietary Restriction in Drosophila$485,000
R01 · FY2009 · AG · contact PI
mRNA Translation, TOR and Geroscience (2 of 11)$475,785
RL1 · FY2009 · AG · contact PI
mRNA Translation, TOR and Geroscience (2 of 11)$475,785
RL1 · FY2008 · AG · contact PI
mRNA Translation, TOR and Geroscience (2 of 11)$485,000
RL1 · FY2007 · AG · contact PI
Regulation of long term feeding and triglyceride storage using Drosophila$236,800
R21 · FY2006 · AG · contact PI
Regulation of long term feeding and triglyceride storage using Drosophila$194,000
R21 · FY2005 · AG